Despite the recently reported national decline in opioid overdose deaths, many U.S. communities, including New Orleans, continue to see an increase in accidental drug-related deaths year over year The ...
3 天
Inquirer on MSNWorld’s first anti-depression nasal spray receives FDA approvalThe US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...
Padagis®, a leading generic manufacturer, announced today it is lowering the price of its over-the-counter (OTC) 4 mg ...
The money will pay for efforts to prevent and treat opioid addiction, or fund services that help people in recovery.
2 天
Livestrong.com on MSNPhenylephrine for Colds: Why It Doesn’t Work and What You Should Use InsteadDiscover why oral phenylephrine in cold medicine is ineffective for relieving congestion. Learn which alternative treatments ...
4 天on MSN
Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with ...
A new clinic in Stratford is offering a nasal ketamine spray to treat mental health conditions. Experts say it’s an option ...
Perhaps the worst part of a cold is a stuffy nose; not being able to breathe as you normally would is zero percent fun.
Discover how a newly recommended immunotherapy works by gradually increasing the body’s resistance to house dust mites.
The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...
A new public health kiosk at the Chippewa County Jail has seen significant use since its launch. It provides essential health ...
UV tanning on sunbeds has been linked to cancer, while other forms of artificial tan come with a risk of organ failure ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果